Recombinant Human NTB-A/SLAMF6 Fc Chimera Protein, CF

Catalog #: 1908-NT Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
1908-NT-050

R&D Systems Recombinant Proteins and Enzymes

1 Image

Product Details

Supplemental Products

Reviews

Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Human NTB-A/SLAMF6 Fc Chimera Protein, CF Summary

Product Specifications

Purity

>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.01 EU per 1 μg of the protein by the LAL method.

Activity

Measured by its ability to bind biotinylated Recombinant Human NTB‑A/SLAMF6 Fc Chimera (Catalog # 1908-NT) in a functional ELISA. Valdez, P.A. et al. (2004) J. Biol. Chem. 279:18662.

Source

Mouse myeloma cell line, NS0-derived human NTB-A/SLAMF6 protein

Human NTB-A (Leu28-Lys225) Accession # Q96DU3	IEGRMD	Human IgG₁ (Pro100-Lys330)
N-terminus		C-terminus

Accession #

Q96DU3

N-terminal Sequence
Analysis

Leu28

Structure / Form

Disulfide-linked homodimer

Predicted Molecular Mass

48.9 kDa (monomer)

SDS-PAGE

55-80 kDa, reducing conditions

Product Datasheets

1908-NT

Product Datasheet

COA

SDS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

1908-NT

Formulation	Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution	Reconstitute at 100 μg/mL in sterile PBS.
Shipping	The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Reconstitution Calculator

Background: NTB-A/SLAMF6

NTB-A (NK-T-B-antigen), also known as Ly108 and SLAMF6, is a 60 kDa type I transmembrane glycoprotein that belongs to the SLAM subgroup of the CD2 family (1). Mature human NTB-A contains a 205 amino acid (aa) extracellular domain (ECD) with one Ig-like V-set and one Ig-like C2-set domain. It also contains a 21 aa transmembrane segment and an 84 aa cytoplasmic domain with two immunoreceptor tyrosine-based switch motifs (ITSMs) (2, 3). An alternately spliced isoform is truncated in the cytoplasmic domain and lacks the two ITSMs. Within the ECD, human NTB-A shares 48% aa sequence identity with mouse and rat NTB-A. The ECD of human NTB-A shares 19%-34% aa sequence identity with comparable regions of human 2B4, BLAME, CD2F-10, CD84, CD229, CRACC, and SLAM. NTB-A is expressed on the surface of NK, T, and B lymphocytes as well as eosinophils (2, 4, 5). It interacts homophilically through weak associations between the Ig-V domains (2, 5-7). NTB-A functions as an activating coreceptor on NK and T cells (2, 5, 6, 8). Tyrosine phosphorylation in the membrane proximal ITSM enables specific association with EAT-2, an interaction that is required for NTB-A mediated cytotoxicity of NK cells (9). Phosphorylation-dependent NTB-A association with SAP is required for full production of IFN-gamma by NK cells (5, 9). This interaction is independent of EAT-2 binding and appears to involve the membrane distal ITSM (5, 9). NTB-A deficient mice show weakened Th2 responses and elevated levels of neutrophil-derived inflammatory mediators (10). On B cells, NTB-A modulates immunoglobulin class switching and the balance between tolerance and autoimmunity (5, 11).

References

Veillette, A. (2006) Immunol. Rev. 214:22.
Bottino, C. et al. (2001) J. Exp. Med. 194:235.
Fraser, C.C. et al. (2002) Immunogenetics 53:843.
Munitz, A. et al. (2005) J. Immunol. 174:110.
Valdez, P.A. et al. (2004) J. Biol. Chem. 279:18662.
Flaig, R.M. et al. (2004) J. Immunol. 172:6524.
Cao, E. et al. (2006) Immunity 25:559.
Stark, S. and C. Watzl (2006) Int. Immunol. 18:241.
Eissmann, P. and C. Watzl (2006) J. Immunol. 177:3170.
Howie, D. et al. (2005) J. Immunol. 174:5931.
Kumar, K.R. et al. (2006) Science 312:1665.

Long Name

NK-T-B Antigen/SLAM Family Member 6

Entrez Gene IDs

114836 (Human)

Alternate Names

Activating NK receptor; CD352 antigen; CD352; KALIFLJ50657; Ly108; NK-T-B-antigen; NTBA receptor; NTBA; NTB-A; NTB-AMGC104953; NTBAT- and B-cell antigen; SF2000; SLAM family member 6; SLAMF6